Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note published on Sunday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.68 on Friday. Retractable Technologies has a 12-month low of $0.56 and a 12-month high of $1.34. The firm has a market cap of $20.45 million, a P/E ratio of -1.26 and a beta of 1.98. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The company’s 50 day moving average is $0.66 and its 200-day moving average is $0.87.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors and hedge funds.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.